Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2495

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-2495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structure of venlafaxine hydrochloride showing the molecular arrangement with a cyclohexane ring, methoxy-substituted benzene ring, and dimethylamino group, labeled with the molecule name at the bottom.*

FDA Label Image

Image-02 (Image 02)

A scatter plot chart showing fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for venlafaxine and its active metabolite ODV across various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age (>60 years), and gender (females/males). The x-axis represents change relative to the reference value.*

FDA Label Image

Image-03 (Image 03)

A chart showing the pharmacokinetic (PK) fold change and 90% confidence intervals for venlafaxine and its ODV metabolite when interacting with various drugs. The chart plots fold changes in Cmax and AUC relative to a reference value for interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Image-04 (Image 04)

A dot plot chart displaying the fold change and 90% confidence intervals for various interacting drugs and analytes, showing pharmacokinetic parameters Cmax and AUC. The x-axis represents change relative to the reference value, ranging from 0 to 3, indicating the impact of different drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium on pharmacokinetic measures.*

FDA Label Image

Label (Lbl713352495)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg, oral dosage form. The label shows 30 capsules per container, labeled as Rx only. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Teva Pharmaceuticals USA Inc. Storage instructions and dispensing guidance are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.